Ana M. Osiceanu
Milan, 20132, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
A Whole-Genome Sequencing Study Implicates GRAMD1B in Multiple Sclerosis Susceptibility.
Journal: Genes
Published: November 15, 2022
A pharmacogenetic study implicates NINJ2 in the response to Interferon-β in multiple sclerosis.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: June 22, 2019
Clinical response to Nabiximols correlates with the downregulation of immune pathways in multiple sclerosis.
Journal: European journal of neurology
Published: November 20, 2017
Laser capture microdissection for transcriptomic profiles in human skin biopsies.
Journal: BMC molecular biology
Published: September 28, 2017
Pharmacogenetic study of long-term response to interferon-β treatment in multiple sclerosis.
Journal: The pharmacogenomics journal
Published: July 03, 2015
Inverse correlation of genetic risk score with age at onset in bout-onset and progressive-onset multiple sclerosis.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: August 05, 2014
Analysis of genes, pathways and networks involved in disease severity and age at onset in primary-progressive multiple sclerosis.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: August 03, 2014
Genetic burden of common variants in progressive and bout-onset multiple sclerosis.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: June 04, 2013
Showing 1-9 of 9
Last Updated: 09/26/2026